Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jul;64(1):128–131. doi: 10.1038/bjc.1991.255

Defective erythropoiesis in primary myelofibrosis associated with a chromosome 11 abnormality.

W N Patton 1, C M Bunce 1, S Larkins 1, G Brown 1
PMCID: PMC1977306  PMID: 1854612

Abstract

A case of primary myelofibrosis was identified with a previously unreported complex karyotype with two abnormal clones in addition to a proportion of normal cells: 46,XY,-2,-11, + der(2)t(2;11) (q24/31;q13), + mar and 45,XY,-2,-11, + der(2)t(2;11)(q24/31;q13), + mar, -17, del(7q). Study of circulating committed progenitors from this patient consistently showed (1) an absence of erythroid progenitors which is uncommon and (2) greatly increased granulocyte-monocyte progenitors (CFU-GM) which is generally observed in myelofibrosis. Further study showed that peripheral blood mononuclear cells co-cultured with irradiated normal bone marrow stroma generated increased numbers of CFU-GM compared with controls but failed to generate erythroid progenitors, providing evidence for an intrinsic defect in erythropoiesis. Only once previously has the absence of erythroid progenitors in primary myelofibrosis been studied in relation to cytogenetic abnormalities. This case also revealed a complex karyotype which, however, shared with our case a defect on chromosome 11. The identification of two cases of primary myelofibrosis which lack committed erythroid progenitor cells and which show in common a chromosomal defect on chromosome 11 point to the existence of genes on this chromosome which play a key role during erythropoiesis.

Full text

PDF
129

Images in this article

130Figure 1
on p.130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ash R. C., Detrick D. A., Zanjani E. D. Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood. 1981 Aug;58(2):309–316. [PubMed] [Google Scholar]
  2. Barosi G., Baraldi A., Cazzola M., Spriano P., Magrini U. Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity. Cancer. 1983 Oct 1;52(7):1290–1296. doi: 10.1002/1097-0142(19831001)52:7<1290::aid-cncr2820520726>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  3. Bentley S. A., Murray K. H., Lewis S. M., Roberts P. D. Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation. Br J Haematol. 1977 May;36(1):41–47. doi: 10.1111/j.1365-2141.1977.tb05753.x. [DOI] [PubMed] [Google Scholar]
  4. Borgström G. H., Knuutila S., Ruutu T., Pakkala A., Lahtinen R., de la Chapelle A. Abnormalities of chromosome 13 in myelofibrosis. Scand J Haematol. 1984 Jul;33(1):15–21. doi: 10.1111/j.1600-0609.1984.tb02204.x. [DOI] [PubMed] [Google Scholar]
  5. Carlo-Stella C., Cazzola M., Gasner A., Barosi G., Dezza L., Meloni F., Pedrazzoli P., Hoelzer D., Ascari E. Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood. 1987 Oct;70(4):1014–1019. [PubMed] [Google Scholar]
  6. Croizat H., Amato D., McLeod D. L., Eskinazi D., Axelrad A. A. Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture. Blood. 1983 Sep;62(3):578–584. [PubMed] [Google Scholar]
  7. Douay L., Laporte J. P., Lefrancois G., Najman A., Dupuy-Montbrun M. C., Lopez M., Giarratana M. C., Gorin N. C. Blood and spleen haematopoiesis in patients with myelofibrosis. Leuk Res. 1987;11(8):725–730. doi: 10.1016/0145-2126(87)90009-9. [DOI] [PubMed] [Google Scholar]
  8. Douer D., Fabian I., Cline M. J. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol. 1983 Jul;54(3):373–381. doi: 10.1111/j.1365-2141.1983.tb02112.x. [DOI] [PubMed] [Google Scholar]
  9. Gartner S., Kaplan H. S. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4756–4759. doi: 10.1073/pnas.77.8.4756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hayman M. J., Kitchener G., Vogt P. K., Beug H. The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8237–8241. doi: 10.1073/pnas.82.23.8237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hibbin J. A., Njoku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol. 1984 Jul;57(3):495–503. doi: 10.1111/j.1365-2141.1984.tb02924.x. [DOI] [PubMed] [Google Scholar]
  12. Jacobson R. J., Salo A., Fialkow P. J. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood. 1978 Feb;51(2):189–194. [PubMed] [Google Scholar]
  13. Johnson D. D., Dewald G. W., Pierre R. V., Letendre L., Silverstein M. N. Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genet Cytogenet. 1985 Nov;18(3):235–241. doi: 10.1016/0165-4608(85)90088-3. [DOI] [PubMed] [Google Scholar]
  14. Partanen S., Ruutu T., Vuopio P. Circulating haematopoietic progenitors in myelofibrosis. Scand J Haematol. 1982 Oct;29(4):325–330. doi: 10.1111/j.1600-0609.1982.tb00602.x. [DOI] [PubMed] [Google Scholar]
  15. Ruutu T., Partanen S., Knuutila S. Clonal karyotype abnormalities in erythroid and granulocyte-monocyte precursors in polycythaemia vera and myelofibrosis. Scand J Haematol. 1983 Sep;31(3):253–256. doi: 10.1111/j.1600-0609.1983.tb00649.x. [DOI] [PubMed] [Google Scholar]
  16. Sato Y., Suda T., Suda J., Ohsaka A., Kubota K., Saito M., Miura Y. Multilineage expression of haemopoietic precursors with an abnormal clone in idiopathic myelofibrosis. Br J Haematol. 1986 Dec;64(4):657–667. doi: 10.1111/j.1365-2141.1986.tb02227.x. [DOI] [PubMed] [Google Scholar]
  17. Sessarego M., Ajmar F., Ravazzolo R., Bianchi Scarrà G. L., Garrè C., Boccaccio P. Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis. Hum Genet. 1983;63(3):299–301. doi: 10.1007/BF00284671. [DOI] [PubMed] [Google Scholar]
  18. Sugiyama H., Ichiba S., Okuno Y., Takahashi T., Imura H., Nakamura K., Iho S., Hoshino T., Okada T., Furukawa H. Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders. Nihon Ketsueki Gakkai Zasshi. 1989 Sep;52(6):1022–1032. [PubMed] [Google Scholar]
  19. Toksoz D., Brown G. Maintenance of granulocyte-monocyte progenitor cells in liquid cultures of human foetal liver. J Cell Physiol. 1984 May;119(2):227–233. doi: 10.1002/jcp.1041190213. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES